OpenCell Technologies Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.76M
- Investors
-
7
OpenCell Technologies General Information
Description
Developer of a cell and gene therapy platform designed to commercialize cell-based analysis techniques and discover new cancer therapies. The company's platform offers high-throughput, and scalable transfection tools to the life science industry, enabling researchers to use difficult-to-transect cells like primary and cancer stem cell cultures and discover new therapeutic cell-based therapies.
Contact Information
Website
www.opencelltech.comCorporate Office
- CORTEX BioScience District, 4340 Duncan Avenue
- BioGenerator, Suite 218
- Saint Louis, MO 63110
- United States
Corporate Office
- CORTEX BioScience District, 4340 Duncan Avenue
- BioGenerator, Suite 218
- Saint Louis, MO 63110
- United States
OpenCell Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Grant | 27-Sep-2021 | $1.76M | Completed | Generating Revenue | ||
| 5. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 4. Grant | 01-Sep-2019 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 16-Mar-2015 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Grant | 05-Aug-2014 | $2.41M | Completed | Startup |
OpenCell Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
OpenCell Technologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
OpenCell Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
OpenCell Technologies Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | |||
| BioGenerator Ventures | Venture Capital | Minority | ||
| Synchrony Bio | Venture Capital | Minority | ||
| National Center for Research Resources | Government | |||
| National Institute of General Medical Sciences | Government |
OpenCell Technologies FAQs
-
When was OpenCell Technologies founded?
OpenCell Technologies was founded in 2008.
-
Where is OpenCell Technologies headquartered?
OpenCell Technologies is headquartered in Saint Louis, MO.
-
What is the size of OpenCell Technologies?
OpenCell Technologies has 7 total employees.
-
What industry is OpenCell Technologies in?
OpenCell Technologies’s primary industry is Biotechnology.
-
Is OpenCell Technologies a private or public company?
OpenCell Technologies is a Private company.
-
What is OpenCell Technologies’s current revenue?
The current revenue for OpenCell Technologies is .
-
How much funding has OpenCell Technologies raised over time?
OpenCell Technologies has raised $344K.
-
Who are OpenCell Technologies’s investors?
National Institutes of Health, BioGenerator Ventures, Synchrony Bio, National Center for Research Resources, and National Institute of General Medical Sciences are 5 of 7 investors who have invested in OpenCell Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
